Jason Hope, one of Arizona’s most prominent tech entrepreneurs, has long talked about the benefits of medical research and the future of medicine that will be unlocked by the cutting-edge research of today.
Jason Hope has long opined, even before it was commonly accepted among medical professionals, that one of the most important aspects of the aging process, the underlying force that causes so many of advancing age’s ill effects, is inflammation and the immune responses that surround it. One such case is atherosclerosis.
Doctors have long understood that atherosclerosis, the leading cause of heart attack and stroke, is driven by the body’s inflammatory immune responses to damage of the endothelial walls of blood vessels. Recently, Hope made a gigantic contribution to the SENS Foundation, a major research institution, to aid in the furtherance of humanity’s knowledge of these processes.
Follow Jason Hope on Twitter.
But just stopping atherosclerosis isn’t Hope’s only goal. Even though atherosclerosis is one of the largest killers in the United States, Hope has his sights set even higher. He points to an increasingly large body of research that indicates that inflammation, the same kind that undergirds atherosclerosis, is the driving force behind everything from wrinkled skin to joint degeneration. In short, Hope believes that unlocking the deepest molecular reasons for atherosclerotic disease will open up new cures, eventually leading to radically increased life expectancies.
Hope thinks that life expectancies in the United States may, within the next 50 years, be able to be pushed to 100 years and beyond, at least for some groups.
Learn more about Jason Hope on https://www.investing.com/members/200946410.